yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33382596-682AFE6D-548B-4A58-8E93-C0F178F82084
Q33382596-682AFE6D-548B-4A58-8E93-C0F178F82084
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33382596-682AFE6D-548B-4A58-8E93-C0F178F82084
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma
P698
Q33382596-682AFE6D-548B-4A58-8E93-C0F178F82084
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33382596-682AFE6D-548B-4A58-8E93-C0F178F82084
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
168badff12b5cd078eb10976c0d0274a740fccb3
P698
19114704
http://www.w3.org/2001/XMLSchema#string